Association of Blood Group O with Gastrointestinal Bleeding in Continuous-Flow LVAD Patients
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2015, Vol 9, Issue 5
Abstract
Background: Increasing use of mechanical circulatory devices for advanced heart failure therapy has led to challenges in managing complications that arise from device implantation for long term support either as a bridge to transplant or as destination therapy. Patients with continuous flow left ventricular assist devices (CF-LVADS) show increasing incidence of gastrointestinal (GI) bleeds. Lack of pulsatality and narrow pulse pressure result in initiation and progression of arteriovenous malformations. High shear forces generated lead to destruction of von Willebrand factor (vWF) making it functionally inactive predisposing patients to increasing bleeding. Literature suggests that patients with blood type O have lower baseline levels of von Willebrand factor. It therefore seemed relevant to study the role of blood groups in this population. Methodology: Retrospective data analysis of 119 CF-LVADS patients discharged between 01/2005 and 07/2014. This study was approved by the Institutional Review Board on 08/01/2014. Results: Blood type (p=0.23), gender (p=0.16) and the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) profile (p=0.86) were not associated with significant incidence of GI bleeding. Blood group O was not associated with a higher incidence of GI bleeding (correlation coefficient =0.07) Patients supported on the HeartMate II (HMII) LVAD experienced more GI bleeding than patients supported on the HeartWare LVAD (HVAD) (p=0.009). HMII LVAD patients who experienced GI bleeding had a mean age of 59.8 years vs. 55.7 years for HMII LVAD patients in the Non-GI bleed group. Age was a significant factor for GI bleeding (p=0.016). Conclusion: Blood group and GI bleeding did not show any significant association in our study. Patients with blood group O did not show increased incidence of GI bleeding despite reported lower baseline levels of von Willebrand factor suggesting contribution of additional factors leading to this complication. The HVAD had a decreased incidence of GI bleeding as compared to Heartmate II. This study is limited by the fact that it was a retrospective analysis in a small population.
Authors and Affiliations
Nandini Nair, Alexa Schmitt, Suzanne Anders, David Sandler, Timothy B. Icenogle
Keywords
Related Articles
- EP ID EP347720
- DOI 10.9734/BJMMR/2015/17863
- Views 91
- Downloads 0
Molecular Biology of Chronic Obstructive Pulmonary Disease from the Bases to the Therapeutic Decision: A Review
Chronic obstructive pulmonary disease (COPD) is a global public health problem. It has an overwhelming prevalence, yet accepted therapies are ineffective in reducing disease progression. Bronchodilators, the mainstay of...
Thyroid and Growth Hormones Interdependence: A “Reciprocal Potentiation”, the Synergy for Growth and Development at Childhood
Aims: To investigate the effect of variations of plasma levels of thyroid and growth hormones on the physical growth indexes, the variation of these hormones with age, correlation of thyroid and growth hormones at varyin...
Evaluation of Diagnostic Methods for Typhoid Fever Disease in Ondo State, Nigeria
Aim: Typhoid fever is caused by Salmonella enteric serovar Typhi and S. enteric serovar Paratyphi A. B. C. Accurate diagnosis of this illness will greatly reduce the mortality and morbidity associated with it. This study...
Primary Lip Leishmaniasis-Report of 4 Cases from a Non-endemic Region of Kashmir Valley of North India and Review of Literature
Leishmaniasis is a disease caused by an intracellular protozoan parasite of the genus Leishmania and transmitted by the bite of a female sandfly(phlebotomus). The clinical spectrum of leishmaniasis ranges from a self-res...
Short Term Rehospitalisation or Death and Determinants after Acute Heart Failure Admission in a Cohort of African Patients in Port Harcourt, Southern Nigeria
Background: Heart failure [HF] is a major health burden globally and contributes significantly to morbidity and mortality related to cardiovascular disease. The aim was to determine the outcome and factors that determine...